Neurogene Inc. Other Nonoperating Expense
Neurogene Inc. (NGNE) reported Other Nonoperating Expense of $7.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2026-08-11
- Neurogene Inc. other nonoperating expense for the quarter ending 2026-06-30 was $7.00K, a 90.54% decline year-over-year.
- Neurogene Inc. other nonoperating expense for the quarter ending 2026-03-31 was $9.00K, a 88.75% decline year-over-year.
- Neurogene Inc. other nonoperating expense for the quarter ending 2025-12-31 was $34.00K, a 91.79% decline year-over-year.
- Neurogene Inc. other nonoperating expense for the quarter ending 2025-09-30 was $42.00K, a 121.05% increase year-over-year.
- Neurogene Inc. other nonoperating expense for fiscal 2025 was $230.00K, a 85.33% decline from fiscal 2024.
- Neurogene Inc. other nonoperating expense for fiscal 2024 was $1.57M, a 5500.00% increase from fiscal 2023.
- Neurogene Inc. other nonoperating expense for fiscal 2023 was $28.00K, a 300.00% increase from fiscal 2022.
- Neurogene Inc. other nonoperating expense for fiscal 2022 was $7.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.00K 10-Q · filed 2026-08-11 | $16.00K 10-Q · filed 2026-08-11 | $50.00K derived: sum of 3 quarters · filed 2026-08-11 | $92.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-12 | $43.00K derived: sum of 2 quarters · filed 2026-05-12 | $85.00K derived: sum of 3 quarters · filed 2026-05-12 | $159.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $76.00K derived: sum of 2 quarters · filed 2026-03-24 | $150.00K derived: sum of 3 quarters · filed 2026-08-11 | $230.00K 10-K · filed 2026-03-24 |
| 2025-09-30 | $42.00K 10-Q · filed 2025-11-13 | $116.00K derived: sum of 2 quarters · filed 2026-08-11 | $196.00K 10-Q · filed 2025-11-13 | $610.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $74.00K 10-Q · filed 2026-08-11 | $154.00K 10-Q · filed 2026-08-11 | $568.00K derived: sum of 3 quarters · filed 2026-08-11 | $587.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $80.00K 10-Q · filed 2026-05-12 | $494.00K derived: sum of 2 quarters · filed 2026-05-12 | $513.00K derived: sum of 3 quarters · filed 2026-05-12 | $1.05M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $414.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $433.00K derived: sum of 2 quarters · filed 2026-03-24 | $966.00K derived: sum of 3 quarters · filed 2026-03-24 | $1.57M 10-K · filed 2026-03-24 |
| 2024-09-30 | $19.00K 10-Q · filed 2025-11-13 | $552.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.15M 10-Q · filed 2025-11-13 | $1.17M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $533.00K 10-Q · filed 2025-08-11 | $1.14M 10-Q · filed 2025-08-11 | $1.15M derived: sum of 3 quarters · filed 2025-08-11 | $1.16M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $602.00K 10-Q · filed 2025-05-09 | $619.00K derived: sum of 2 quarters · filed 2025-05-09 | $623.00K derived: sum of 3 quarters · filed 2025-05-09 | $627.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $21.00K derived: sum of 2 quarters · filed 2025-03-24 | $25.00K derived: sum of 3 quarters · filed 2025-03-24 | $28.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $4.00K 10-Q · filed 2024-11-18 | $8.00K derived: sum of 2 quarters · filed 2024-11-18 | $11.00K 10-Q · filed 2024-11-18 | |
| 2023-06-30 | $4.00K 10-Q · filed 2024-08-09 | $7.00K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $3.00K 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $7.00K 10-K · filed 2024-03-18 | |||
| 2020-03-31 | $20.00K 10-Q · filed 2020-05-06 | |||
| 2019-03-31 | $1.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |